Trial Profile
A Randomized Gene Fusion Stratified Phase 2 Trial of Abiraterone With or Without ABT-888 for Patients With Metastatic Castration-Resistant Prostate Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Veliparib (Primary) ; Abiraterone acetate; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- 21 Oct 2020 Status changed from active, no longer recruiting to completed.
- 25 Mar 2020 Planned primary completion date changed from 31 Jan 2020 to 1 Feb 2021.
- 25 Apr 2019 Planned primary completion date changed from 31 Jan 2019 to 31 Jan 2020.